1.
Hosp Pract (Off Ed)
; 21(9A): 99-107, 111, 114-27, 1986 Sep 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-2876002
RESUMO
This is the era of polypharmacy. Treatment with multiple therapeutic agents for multiple underlying medical conditions leads to greater vulnerability to such metabolic imbalances as hyperkalemia. The physician must know which underlying medical conditions and drugs predispose to abnormal intracellular-extracellular potassium balance and abnormal regulation of potassium excretion.